Draft:SML BIOPHARM

SML BIOPHARM
Company type	Public
Industry	Biotechnology
Founded	2021; 3 years ago
Founders	JaeHwan Nam;
Headquarters	Gwangmyeong-si, Republic of Korea,
Area served	Worldwide
Key people	JaeHwan Nam (CEO); Daegeun Kim (COO);
Number of employees	13 (2024)
Website	www.smlbiopharm.com/eng/main/

Submission declined on 11 June 2024 by Relativity (talk).

This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are:

in-depth (not just brief mentions about the subject or routine announcements)
reliable
secondary
strictly independent of the subject

Make sure you add references that meet all four of these criteria before resubmitting. Learn about mistakes to avoid when addressing this issue. If no additional references exist, the subject is not suitable for Wikipedia.

This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies.

If you would like to continue working on the submission, click on the "Edit" tab at the top of the window.
If you have not resolved the issues listed above, your draft will be declined again and potentially deleted.
If you need extra help, please ask us a question at the AfC Help Desk or get live help from experienced editors.
Please do not remove reviewer comments or this notice until the submission is accepted.

Where to get help

If you need help editing or submitting your draft, please ask us a question at the AfC Help Desk or get live help from experienced editors. These venues are only for help with editing and the submission process, not to get reviews.
If you need feedback on your draft, or if the review is taking a lot of time, you can try asking for help on the talk page of a relevant WikiProject. Some WikiProjects are more active than others so a speedy reply is not guaranteed.

How to improve a draft

Wikipedia:Contributing to Wikipedia – a basic overview on how to edit Wikipedia.
Help:Wikitext – how to use the markup
Help:Referencing for beginners – how to include references
Wikipedia:Article development – how to develop your article
Wikipedia:Writing better articles – how to improve your article
Wikipedia:Verifiability – make sure your article includes reliable third-party sources

You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article.

Improving your odds of a speedy review

To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags.

Add tags to your draft

Editor resources

Easy tools: Citation bot (help) | Advanced: Fix bare URLs

Declined by Relativity 5 months ago. Last edited by Relativity 5 months ago. Reviewer: Inform author.

Resubmit

Please note that if the issues are not fixed, the draft will be declined again.

SML Biopharm (SML바이오팜) is a South Korean biotechnology company based in Gwangmyeong-si that develops for patient-specific approaches to the treatment of diseases. SML Biopharm aims to become a global leader specializaing in the research and development of next-generation mRNA vaccines. SML Biopharm leads the development of preventing vaccines and therapeutics using cuttingedge mRNA platform technology, pioneering innovations in pharmaceuticals to enhance the health and well-being of humanity in the future.